OMIP-037: 16-color panel to measure inhibitory receptor signatures from multiple human immune cell subsets

被引:15
作者
Belkina, Anna C.
Snyder-Cappione, Jennifer E. [1 ]
机构
[1] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA
关键词
immune cell; checkpoint inhibition; T cell; NK cell; iNKT cell; inhibitory receptors; PD-1; TIGIT; CD160; LAG-3; TIM-3; cancer; tumor; TUMOR-INFILTRATING LYMPHOCYTES; MHC CLASS-I; T-CELLS; ACTIVATION GENE-3; PD-1; BLOCKADE; EXHAUSTION; LIGAND; NIVOLUMAB; RESPONSES; TIM-3;
D O I
10.1002/cyto.a.22983
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
[No abstract available]
引用
收藏
页码:175 / 179
页数:5
相关论文
共 45 条
[1]   PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma [J].
Ansell, Stephen M. ;
Lesokhin, Alexander M. ;
Borrello, Ivan ;
Halwani, Ahmad ;
Scott, Emma C. ;
Gutierrez, Martin ;
Schuster, Stephen J. ;
Millenson, Michael M. ;
Cattry, Deepika ;
Freeman, Gordon J. ;
Rodig, Scott J. ;
Chapuy, Bjoern ;
Ligon, Azra H. ;
Zhu, Lili ;
Grosso, Joseph F. ;
Kim, Su Young ;
Timmerman, John M. ;
Shipp, Margaret A. ;
Armand, Philippe .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) :311-319
[2]   CHARACTERIZATION OF THE LYMPHOCYTE-ACTIVATION GENE 3-ENCODED PROTEIN - A NEW LIGAND FOR HUMAN-LEUKOCYTE ANTIGEN CLASS-II ANTIGENS [J].
BAIXERAS, E ;
HUARD, B ;
MIOSSEC, C ;
JITSUKAWA, S ;
MARTIN, M ;
HERCEND, T ;
AUFFRAY, C ;
TRIEBEL, F ;
PIATIERTONNEAU, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (02) :327-337
[3]   Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer [J].
Brahmer, Julie ;
Reckamp, Karen L. ;
Baas, Paul ;
Crino, Lucio ;
Eberhardt, Wilfried E. E. ;
Poddubskaya, Elena ;
Antonia, Scott ;
Pluzanski, Adam ;
Vokes, Everett E. ;
Holgado, Esther ;
Waterhouse, David ;
Ready, Neal ;
Gainor, Justin ;
Aren Frontera, Osvaldo ;
Havel, Libor ;
Steins, Martin ;
Garassino, Marina C. ;
Aerts, Joachim G. ;
Domine, Manuel ;
Paz-Ares, Luis ;
Reck, Martin ;
Baudelet, Christine ;
Harbison, Christopher T. ;
Lestini, Brian ;
Spigel, David R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (02) :123-135
[4]   CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator [J].
Cai, Guifang ;
Anumanthan, Anukanth ;
Brown, Julia A. ;
Greenfield, Edward A. ;
Zhu, Baogong ;
Freeman, Gordon J. .
NATURE IMMUNOLOGY, 2008, 9 (02) :176-185
[5]   Proliferation Capacity and Cytotoxic Activity Are Mediated by Functionally and Phenotypically Distinct Virus-Specific CD8 T Cells Defined by Interleukin-7Rα (CD127) and Perforin Expression [J].
Cellerai, Cristina ;
Perreau, Matthieu ;
Rozot, Virginie ;
Enders, Felicitas Bellutti ;
Pantaleo, Giuseppe ;
Harari, Alexandre .
JOURNAL OF VIROLOGY, 2010, 84 (08) :3868-3878
[6]   SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation [J].
Chemnitz, JM ;
Parry, RV ;
Nichols, KE ;
June, CH ;
Riley, JL .
JOURNAL OF IMMUNOLOGY, 2004, 173 (02) :945-954
[7]   TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection [J].
Chew, Glen M. ;
Fujita, Tsuyoshi ;
Webb, Gabriela M. ;
Burwitz, Benjamin J. ;
Wu, Helen L. ;
Reed, Jason S. ;
Hammond, Katherine B. ;
Clayton, Kiera L. ;
Ishii, Naoto ;
Abdel-Mohsen, Mohamed ;
Liegler, Teri ;
Mitchell, Brooks I. ;
Hecht, Frederick M. ;
Ostrowski, Mario ;
Shikuma, Cecilia M. ;
Hansen, Scott G. ;
Maurer, Mark ;
Korman, Alan J. ;
Deeks, Steven G. ;
Sacha, Jonah B. ;
Ndhlovu, Lishomwa C. .
PLOS PATHOGENS, 2016, 12 (01)
[8]   Molecular and Transcriptional Basis of CD4+ T Cell Dysfunction during Chronic Infection [J].
Crawford, Alison ;
Angelosanto, Jill M. ;
Kao, Charlly ;
Doering, Travis A. ;
Odorizzi, Pamela M. ;
Barnett, Burton E. ;
Wherry, E. John .
IMMUNITY, 2014, 40 (02) :289-302
[9]   Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation [J].
Freeman, GJ ;
Long, AJ ;
Iwai, Y ;
Bourque, K ;
Chernova, T ;
Nishimura, H ;
Fitz, LJ ;
Malenkovich, N ;
Okazaki, T ;
Byrne, MC ;
Horton, HF ;
Fouser, L ;
Carter, L ;
Ling, V ;
Bowman, MR ;
Carreno, BM ;
Collins, M ;
Wood, CR ;
Honjo, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) :1027-1034
[10]   Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma [J].
Hamid, Omid ;
Robert, Caroline ;
Daud, Adil ;
Hodi, F. Stephen ;
Hwu, Wen-Jen ;
Kefford, Richard ;
Wolchok, Jedd D. ;
Hersey, Peter ;
Joseph, Richard W. ;
Weber, Jeffrey S. ;
Dronca, Roxana ;
Gangadhar, Tara C. ;
Patnaik, Amita ;
Zarour, Hassane ;
Joshua, Anthony M. ;
Gergich, Kevin ;
Elassaiss-Schaap, Jeroen ;
Algazi, Alain ;
Mateus, Christine ;
Boasberg, Peter ;
Tumeh, Paul C. ;
Chmielowski, Bartosz ;
Ebbinghaus, Scot W. ;
Li, Xiaoyun Nicole ;
Kang, S. Peter ;
Ribas, Antoni .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (02) :134-144